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Abstract
Background: The transcription factor Snail1 induces epithelial-to-mesenchymal transition (EMT), a process responsible for
the acquisition of invasiveness during tumorigenesis. Several transcriptomic studies have reported Snail1-regulated genes in
different cell types, many of them involved in cell adhesion. However, only a few studies have used proteomics as a tool for
the characterization of proteins mediating EMT.
Methodology/Principal Findings: We identified by proteomic analysis using 2D-DIGE electrophoresis combined with
MALDI-TOF-TOF and ESI-linear ion trap mass spectrometry a number of proteins with variable functions whose expression is
modulated by Snail1 in SW480-ADH human colon cancer cells. Validation was performed by Western blot and
immunofluorescence analyses. Snail1 repressed several members of the 14-3-3 family of phosphoserine/phosphothreonine
binding proteins and also the expression of the Proliferation-associated protein 2G4 (PA2G4) that was mainly localized at
the nuclear Cajal bodies. In contrast, the expression of two proteins involved in RNA processing, the Cleavage and
polyadenylation specificity factor subunit 6 (CPSF6) and the Splicing factor proline/glutamine-rich (SFPQ), was higher in
Snail1-expressing cells than in controls. The regulation of 14-3-3e, 14-3-3t, 14-3-3f and PA2G4 by Snail1 was reproduced in
HT29 colon cancer cells. In addition, we found an inverse correlation between 14-3-3s and Snail1 expression in human
colorectal tumors.
Conclusions/Significance: We have identified a set of novel Snail1 target proteins in colon cancer that expand the cellular
processes affected by Snail1 and thus its relevance for cell function and phenotype.
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Introduction
The transcription factor Snail1 regulates the biology of
fibroblasts and its upregulation in epithelial cells causes a change
to a mesenchymatic phenotype, a process known as epithelial-to-
mesenchymal transition (EMT). This is a transdifferentiation shift
in which epithelial cells lose adhesiveness and polarity and acquire
the spindle morphology and migratory capacity characteristic of
fibroblasts as a result of a drastic alteration in the gene expression
profile [1,2]. EMT plays important physiological roles during
embryogenesis and wound healing, and is also crucial for the
acquisition of tumoral invasiveness, the initial step of the
metastatic cascade in cancer [1,2].
Snail1 appears to have a master role in EMT, although several
other factors such as Snail2 (Slug), Zeb1 (dEF1), Zeb2 (Sip1),
Twist1, E47 and E2-2 are also known to induce or contribute to
the EMT in different types of cells [2,3]. These factors promote
partially different gene expression profiles that have in common
the repression of genes encoding adhesion proteins (E-cadherin,
Occludin and several claudins) and the induction of mesenchymal
markers such as Vimentin, Fibronectin, and proteases and factors
that promote cell movement [3,4]. Snail1 was the first character-
ized repressor of the invasion suppressor gene CDH1 that encodes
for the crucial adhesion protein E-cadherin [5,6]. In addition,
Snail1 has recently been shown to activate Wnt/b-Catenin
signaling and Nuclear factor kappa B activity [7,8], and it
abrogates the inhibition of Wnt/b-Catenin pathway caused by
the antitumoral compound 1a,25-dihydroxyvitamin D3 [9].
Snail1 is upregulated in several human cancers and is frequently
associated with invasiveness, metastases and poor prognosis [3].
Snail1 RNA is undetectable in normal colon mucosa but it
becomes upregulated in 60–70% of colon cancers [10–12]. A
recent study has shown that Snail1 protein is expressed in 79% of
colon tumors, usually in the tumor-stroma interphase. Snail1 is
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found in both the epithelial tumor tissue and the adjacent stroma
in 56% of colon tumors, whereas in 21% of the cases it is only
present in stromal cells with fibroblastic phenotype [13].
A number of studies have focused on the transcriptomic analysis
of the EMT promoted by Snail1 and other transcription factors, or
by genes or agents such as oncogenic Ras or Transforming growth
factor b that induced them [4,14–17]. However, only a few studies
have used proteomics as a tool for the characterization of proteins
mediating EMT [18]. The majority of these studies have employed
2D-PAGE followed by MALDI-TOF mass spectrometry to
identify proteins differentially-expressed in tumor tissues and/or
cell lines [18–20]. A few studies have used iTRAQ technology
followed by 2D-LC separation of peptides and mass spectrometry
[18,21,22]. Here, we have used 2D-DIGE technology followed by
MALDI-TOF-TOF and ESI-linear ion trap mass spectrometry.
The combination of these techniques is a more sensitive and
reliable approach for the identification of minor differences in
protein expression between human colon cancer cells with low or
high levels of Snail1. These techniques have given us the
opportunity to take a deeper insight into the proteomic changes
associated to Snail1 overexpression. In this study, we have
identified a number of proteins previously unknown as Snail1
targets in human colon cancer cells. Some of them are involved in
the control of cellular gene expression and phenotype, and are
probable mediators of the tumorigenic action of Snail1.
Results
Most genes previously characterized as regulated by Snail1
encode plasma membrane proteins involved in cell adhesion or
cytoskeletal components. To widen our knowledge of Snail1 effects
in human colon cancer, we employed an integrative strategy to
identify nuclear proteins regulated by Snail1 in this neoplasia
(Figure 1A). We used 2D-DIGE electrophoresis combined with
MALDI-TOF-TOF and ESI-linear ion trap mass spectrometry to
compare the pattern of proteins present in nuclear extracts from
human colon cancer SW480-ADH cells expressing a retrovirally-
transduced Snail1 cDNA (Snail1 cells) with that of mock-infected
cells (Mock cells). A subset of the identified proteins was validated
by Western blot and immunofluorescence analyses of human
colon cancer cells, and by immunohistochemistry of human colon
cancer biopsies. We have previously characterized the cellular
model used in this study [7,10] and found that Snail1
overexpression promoted the acquisition of a more stellate cell
morphology (Figure 1B), the repression of the epithelial markers E-
cadherin, Occludin and Claudin-7, and the induction of the
mesenchymal protein Lef-1 (Figure 1C).
Differential protein expression analysis of nuclear
fractions from human colon cancer cells with high or low
Snail1 expression
Nuclear extracts from SW480-ADH Mock and Snail1 cells were
analyzed by 2D-DIGE as described in Materials and Methods.
Protein pattern changes were quantitatively and statistically
analyzed by using the DeCyder software v.6.5 considering the
12 spot maps included in the study. Figure 2 shows a
representative 2D map of the nuclear SW480-ADH proteins.
Each gel was analyzed individually to calculate the volume ratios
between individual samples and the internal pool, which was used
as the standard reference. Then, all the images were combined
and analyzed together by using the BVA module. Few variations
in protein abundance were observed between Mock and Snail1
cells. A paired t-test was used to select 22 spots whose expression
variation between both cell types was statistically significant
(Student’s t-test, p,0.05). These spots were selected as spots of
interest and annotated on the master gel (Figure 2). Protein
identification was performed by two methods: (1) peptide mass
fingerprinting using MALDI-TOF-TOF and (2) ESI-linear ion
trap and MS/MS peptide sequencing (applying a restrictive false
positive discovery rate (FDR) cut-off, FDR#1%). In both cases,
identification with more than one peptide was a requisite. By using
this double approach, 19 proteins were identified in 17 out of 22
spots (Table 1). Only five proteins were identified by MALDI-
TOF-TOF due to the low levels of expression. Eighteen proteins
were identified by ESI-linear ion trap, with two spots containing
more than one protein. In those cases, proteins were listed
according to the number of identified peptides. Four proteins were
identified by both techniques (Table 1).
Protein ontology analysis of identified proteins
Among the proteins altered by Snail1 overexpression we
identified a-Catenin (CTNNA1), the PI3K regulatory subunit a
(PIK3R1), Caldesmon (CALD1), the Cleavage and polyadenyla-
tion specificity factor subunit 6 (CPSF6), and Vimentin (VIM) as
upregulated proteins; and Proliferation-associated protein 2G4
(PA2G4, also known as ErbB3-binding protein 1 or EBP1), Ran-
specific GTPase-activated protein (RANBP1), and several mem-
bers of the 14-3-3 protein family (YWHAE, YWHAH and
YWHAQ) among the downregulated proteins (Table 1). Despite
working with nuclear extracts, only 7 out of 19 proteins were
assigned to the nuclear compartment (CPSF6, WTAP, ENO1,
PA2G4, HNRNPH3, RANBP1 and PPIA), while the remaining
were preferentially cytosolic or associated to the cytoskeleton.
However, we cannot discard that the latter proteins were partially
or temporarily present in the nuclear compartment. Regarding
biological function, several proteins were involved in cell adhesion
(CTNNA1) or components of the cytoskeleton (CALD1, VIM and
LASP1). However, most of the proteins were implicated in signal
transduction (PI3KR1, RANBP1 and the 14-3-3 family members)
and RNA processing (CPSF6, WTAP and HNRNPH3) (Table 1).
Some of these proteins were selected for validation. Given the high
homology existing among the 14-3-3 proteins and between some
of the identified peptides (i.e. –VISSIEQK– for 14-3-3t and –
VLSSIEQK– for 14-3-3s, which makes them virtually indistin-
guishable), we decided to include all the members of the family in
the validation analyses.
Validation of candidate target proteins
For a quantitative estimation of the expression of the candidate
target proteins in SW480-ADH Mock and Snail1 cells, we
analyzed by Western blot three nuclear extracts prepared
independently (N1, N2, N3). Additionally, the cytosolic extracts
from one of the experiments (C1) were included in the analysis
(Figure 3A). Variable downregulation (20% to 70%) of 14-3-3 b, e,
s, t and f proteins were found in the nucleus of Snail1 cells. For
all of them except 14-3-3s the downregulation was weaker in the
cytosol than in the nucleus (Figure 3A). We have been unable to
detect 14-3-3g expression neither in the nucleus nor in the cytosol,
whereas that of 14-3-3c was unaffected by Snail1 overexpression
(data not shown). PA2G4 expression was also lower in both
nucleus and cytosol of SW480-ADH Snail1 than in Mock cells
(Figure 3A).
By contrast, the level of CPSF6 was higher in Snail1 cells than
in Mock cells (Figure 3A). We have also analyzed the expression of
Splicing factor proline/glutamine-rich (SFPQ), a protein found
1.59-fold upregulated in the proteomic analysis, but absent from
Table 1 because it was identified only with one peptide in spot
609. We did so because both SFPQ and CPSF6 are involved in
Proteins Regulated by Snail1
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Figure 1. Experimental workflow and characterization of SW480-ADHMock and Snail1 cells. (A) Scheme of the workflow followed in this
study. (B) Representative phase-contrast micrographs (upper panels) and confocal laser immunofluorescence images showing F-actin staining (lower
panels) of SW480-ADH Mock and Snail1 cells. Scale bar, 20 mm (upper panels) and 10 mm (lower panels). (C) Western blot analysis of whole-cell
Proteins Regulated by Snail1
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pre-mRNA processing and localized in nuclear paraspeckles [23],
which suggests a possible coordinated effect of Snail1. Indeed, we
found that Snail1 increased nuclear SFPQ expression and also the
low level of SFPQ detected in the cytosol (Figure 3A).
The regulation by Snail1 was complex in the case of the
Heterogeneous nuclear ribonucleoprotein H3 (HNRNPH3),
which presents several isoforms resulting from alternative splicing
[24]. The peptides used in the proteomic study to identify
HNRNPH3 indicate that the downregulated spot may only
correspond to isoforms 1, 2 or 3. The analysis by Western blot
showed that the expression of isoforms 1 and 2 (predicted MW
36.9 and 35.2 kDa, respectively) was upregulated by Snail1, while
that of isoforms 3 and 4 (predicted MW 31.5 and 22.3 kDa,
respectively) was strongly downregulated in both nucleus and
cytosol of Snail1 cells (Figure 3A). Therefore, the protein identified
in the proteomic analysis must be isoform 3 of HNRNPH3.
The repression of 14-3-3e, 14-3-3t, 14-3-3f and PA2G4 by
Snail1 in nuclear extracts was reproduced in two independent
experiments in another human colon cancer cell line, HT29
(Figure 3B). In addition, quantitative RT-PCR analysis revealed a
decreased level of PA2G4 RNA in both SW480-ADH and HT29
cells expressing Snail1 as compared to their respective Mock cells
(Figure 3C).
Subcellular distribution of Snail1 target proteins
The expression of some of the Snail1 target proteins validated
by Western blot was further studied by immunofluorescence and
confocal microscopy analyses. As shown in Figure 4, the level of
14-3-3 b, e and s was much lower in both nucleus and cytosol of
SW480-ADH Snail1 cells than in Mock cells. In all three cases the
expression was higher in the cytosol than in the nucleus with a
variable ratio: b,s,e. Immunofluorescence analysis also showed
a reduction of both nuclear and cytosolic expression of PA2G4 in
Snail1 cells compared to Mock cells (Figure 5A). The expression of
PA2G4 had a fine punctate pattern in both nucleus and cytosol,
and was particularly strong in a few round and sharply defined
nuclear foci of approximately 0.5 mm in diameter (Figure 5).
Double staining using antibodies against Coilin (marker of Cajal
bodies), the TMG-cap of spliceosomal snRNAs (marker of Cajal
bodies and nuclear speckles of splicing factors), Fibrillarin (marker
of nucleolus) and PML (marker of PML bodies) indicated that the
PA2G4-positive nuclear foci correspond to Cajal bodies
(Figure 5B). This result was confirmed in neurons (data not
shown), the cell type where the Cajal bodies are most prominent
[25]. The best understood function of Cajal bodies is the
biogenesis of small nuclear and nucleolar RNPs (snRNPs,
snoRNPs) involved in pre-mRNA splicing and pre-rRNA
processing, respectively [25,26]. The double staining experiments
also showed a faint staining of PA2G4 in the nucleolus (see
Figure 5B, PA2G4 and Fibrillarin co-staining), as it has been
previously described [27].
Analysis of human colon tumors
The repression of several 14-3-3 family members by a tumor-
associated transcription factor as Snail1 prompted us to study the
expression of these proteins in human colon cancer. As 14-3-3s
was the member which expression was more strongly repressed by
Snail1 both in the nucleus and in the cytosol, we selected it for the
study on human samples. First, we analyzed 14-3-3s expression by
immunohistochemistry in a tissue array containing paired normal
and tumor samples from 46 colorectal cancer patients, and found
that 14-3-3s was highly expressed by both normal and tumor
epithelial cells but not by stromal cells (Figure 6A). As this
expression pattern of 14-3-3s was coherent with its repression by
an inducer of EMT such us Snail1, we decided to perform a more
detailed study of 14-3-3s and Snail1 expression in consecutive
slices of five colon tumor biopsies. In agreement with previous
studies [13], we mainly found Snail1 immunoreactivity in the
nucleus of cells with mesenchymal phenotype within the tumor
(Figure 6B). These cells could correspond to tumor epithelial cells
that have undergone EMT and/or fibroblasts that have been
activated by the tumor microenvironment [13]. Accordingly with
the data obtained from the tissue array, 14-3-3s was expressed in
both nucleus and cytosol of tumor epithelial cells, but it was absent
in stromal cells (Figure 6B). Therefore, 14-3-3s and Snail1 have
opposite expression patterns (epithelial and stromal, respectively)
in colon cancer. In addition, 14-3-3s expression closely resembles
that of the Snail1 target gene CDH1/E-cadherin and, as proposed
Figure 2. Differential protein expression analysis of SW480-
ADH Snail1 and Mock cells by 2D-DIGE electrophoresis. Nuclear
extracts from SW480-ADH Mock and Snail1 cells were differentially
labeled with Cy3 and Cy5 dyes. An internal standard combining
proteins from both extracts was included in all gels after labeling with
Cy2 dye. 3–10 NL IPG strips were used for the IEF and standard SDS-
PAGE for the second dimension. Representative 2D image shows the
spot map corresponding to the internal standard, which is common to
all gels analyzed. Spots indicated with arrows were informative for
protein identification by mass spectrometry (see Table 1 for code
assignment). Selected spots showed a statistical variance of volume
ratios within the 95th confidence level (Student’s t-test, p,0.05).
doi:10.1371/journal.pone.0010221.g002
extracts from SW480-ADH Mock and Snail1 cells showing Snail1 overexpression and its effect on the expression of epithelial (E-cadherin, Occludin
and Claudin-7) and mesenchymal (Lef-1) markers. b-Tubulin was used as a loading control.
doi:10.1371/journal.pone.0010221.g001
Proteins Regulated by Snail1
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for this gene, it is possible that Snail1 represses 14-3-3s expression
in mesenchymal cells.
Discussion
Identifying proteins regulated by Snail1 widens the present
knowledge on the biology of this transcription factor and sheds
new light on the mechanisms of EMT and cancer progression. We
chose colon cancer as a working system because Snail1 is
upregulated at both RNA and protein level in this neoplasia and
contributes to its malignization [10–13]. Previously, the gene
expression profiles induced by Snail1 in different systems had been
studied by transcriptomic analyses, and most of the Snail1 target
genes identified encoded for proteins involved in cellular adhesion,
extracellular matrix and cytoskeleton [4,15,28]. In this study, we
performed a proteomic analysis of nuclear extracts aimed to
identify novel proteins regulated by Snail1 that could mediate its
wide effects on cell physiology and phenotype.
Our study shows a remarkable conservation in the global
pattern of nuclear protein expression in human colon cancer cells
that express high or low levels of Snail1. Still, a series of previously
uncharacterized Snail1-regulated proteins implicated in diverse
cell functions have been identified. Twenty-two spots were found
as significantly deregulated between both cell types with a p,0.05
(Student’s t-test). Nineteen different proteins were identified, most
of them by using the ESI-linear ion trap instrument in
combination with a nano-HPLC. Only five proteins were
identified by MALDI-TOF-TOF, probably due to the low
expression of the proteins present in the spots. Two spots (1419
and 1926) contained more than one protein. However, in spot
1419, Vimentin was significantly more abundant (based on the
number of identified peptides) than the other proteins and we
assigned to it the differences in expression. In spot 1926, the
number of identified peptides was quite similar between LASP1
and HNRNPH3, making more difficult the assignation of the
differential expression.
Our results agree with the transcriptional repressor role of
Snail1, as in 12 out of the 17 spots with identified proteins the
expression was lower in Snail1-expressing cells than in Mock cells,
while only in five of them the expression was higher in Snail1 cells.
The repression of the downregulated proteins could be a direct
effect of Snail1, especially in the case of PA2G4 whose RNA level
was also reduced by Snail1. By contrast, the induction of protein
expression by Snail1 must be indirect, mediated by other
transcription factors, as it has been reported for Matrix
metalloproteases 2 and 9 [29,30]. In addition, we found that
Snail1 alters the splicing pattern of HNRNPH3 in SW480-ADH
cells. This is in line with studies describing that Snail1 changes the
Table 1. List of proteins differentially expressed in SW480-ADH Snail1 and Mock cells.
Spot No.
SwissProt
Access. No. Gene symbol Protein name MW (Da) pI
Seq. cov.
(%)/No. pept.a
Av.
ratiob Function
609 P35221 CTNNA1 Catenin alpha 1 100,071 5.95 2.54/2 1.59 Cell adhesion
964 P27986 PIK3R1 PI3K regulatory subunit alpha 83,598 5.84 4.97/3 2.31 PI3K cascade
971 Q05682 CALD1 Caldesmon 93,250 5.63 12.99/12 3.61 Actin binding
1168 Q16630 CPSF6 Cleavage and polyadenylation specificity factor
subunit 6
9,210 6.66 4.39/2 1.99 mRNA
processing
1419 P08670 VIM Vimentin 53,652 5.06 27.25/21 1.66 Cytoskeleton
P06576 ATP5B Mitochondrial ATP synthase subunit beta 56,560 5.26 4.54/4 Proton transport
Q15007 WTAP Pre-mRNA splicing regulator WTAP 44,244 5.12 7.07/2 RNA splicing
1576 P06733 ENO1 Alpha enolase 47,169 7.37 16.59/10 22.47 Transcription
regulator
1587 O60884 DNAJA2 DnaJ homolog subfamily A member 2 45,746 6.06 4.85/2 22.14 Protein binding
1604 Q9UQ80 PA2G4 Proliferation-associated protein 2G4 43,787 6.13 5.58/4 21.51 Cell proliferation
1829 P07355 ANXA2 Annexin A2 38,604 7.57 3.20/2 24.10 Phospholipase
inhibitor
1926 Q14847 LASP1 LIM and SH3 domain protein 1 29,717 6.61 15.71/8 22.44 Actin binding
P31942 HNRNPH3 Heterogeneous nuclear ribonucleoprotein H3 36,926 6.37 10.12/5 RNA binding
2122 P62258 YWHAE 14-3-3 protein epsilon 29,174 4.63 14.12/3 21.67 Cell signaling
2131 P62258 YWHAE 14-3-3 protein epsilon 29,174 4.63 9.41/2 21.78 Cell signaling
2181 Q04917 YWHAH 14-3-3 protein eta 28,219 4.76 10.57/2 22.26 Cell signaling
2189 P27348 YWHAQ 14-3-3 protein tau 27,764 4.68 5.30/4 21.97 Cell signaling
2197 P43487 RANBP1 Ran-specific GTPase-activating protein 23,310 5.19 10.95/3 21.88 Ran GTPase
2265 P13693 TPT1 Translationally-controlled tumor protein 1 19,595 4.84 32.00/68 21.89 Apoptosis
2373 P62937 PPIA Peptidyl-prolyl cis-trans isomerase A 18,012 7.68 7.88/2 22.80 Protein folding
All the listed proteins showed a statistical difference of spot volume ratio between SW480-ADH Snail1 and Mock cells within the 95th confidence level (Student’s t-test,
p,0.05).
The majority of the proteins were identified only by ESI-linear ion trap, except of TPT1 that was identified by MALDI-TOF-TOF, and VIM, ENO1, PA2G4 and LASP1 that
were identified using both techniques.
aSequence coverage (%) and number of peptides identified with #1% FDR (false discovery rate cut-off against decoy-concatenated randomized database). Coverage
and FDR were determined by SEQUEST algorithm for all proteins except for TPT1, which score was determined by MASCOT algorithm.
bAverage ratio of protein expression between SW480-ADH Snail1 and Mock cells.
doi:10.1371/journal.pone.0010221.t001
Proteins Regulated by Snail1
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pattern of splicing of p120-Catenin and Zonula occludens-1 by
uncharacterized mechanisms [31,32].
In agreement with previous transcriptomic studies, we show
here that Snail1 changes the expression of proteins involved in
cell adhesion and cytoskeleton (CTNNA1, CALD1, VIM and
LASP1). Additionally and to our knowledge for the first time, we
report that Snail1 regulates proteins involved in other cellular
functions as RNA maturation (CPSF6, HNRNPH3 and SFPQ)
and intracellular signaling (PI3KR1, RANBP1 and 14-3-3
protein family). The almost general repressive effect of Snail1
on the expression of 14-3-3 family members is surprising and
agrees with the recently proposed cancer-protecting role of
certain of these proteins [33,34]. The 14-3-3 proteins have for
long been known as phosphoserine/phosphothreonine binding
Figure 3. Validation of candidate Snail1 target proteins. (A) Western blot analysis of the expression of selected proteins in cytosolic (C) and
nuclear (N) extracts of SW480-ADH Mock and Snail1 cells. HNRNPH3 isoforms (1–4) are indicated. The numbers below the gels indicate the
quantification of the change in expression between Snail1 and Mock cells after normalization to b-Tubulin or Lamin B (cytosolic and nuclear control,
respectively). The statistical significance of the nuclear expression changes promoted by Snail1 was assessed by two-tailed unpaired Student’s t-test.
It was p,0.001 for 14-3-3e, 14-3-3s, 14-3-3f, CPSF6 and the isoforms 3 and 4 of HNRNPH3; p,0.01 for 14-3-3t; and p,0.05 for 14-3-3b and PA2G4.
The regulation of SFPQ (p = 0.057) and that of the isoforms 1+2 of HNRNPH3 (p = 0.058) did not reached the statistical significance, but a clear
tendency was observed. (B) Western blot analysis of the expression of selected proteins in cytosolic (C) and nuclear (N) fractions of HT29 Mock and
Snail1 cells. The numbers below the gels indicate the quantification of the change in expression between Snail1 and Mock cells after normalization to
b-Tubulin or Lamin B (cytosolic and nuclear control, respectively). (C) Quantitative RT-PCR study of PA2G4 expression in SW480-ADH and HT29 Mock
and Snail1 cells. 18S rRNA expression was used for normalization. Statistical significance was assessed by two-tailed unpaired Student’s t-test, single
asterisk indicates p,0.05.
doi:10.1371/journal.pone.0010221.g003
Proteins Regulated by Snail1
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proteins able to bind and modulate the interaction between
proteins and involved in cell processes as signaling, cell cycle
control, apoptosis, intracellular trafficking, cytoskeletal structure
and transcription [34,35]. Only in recent years several 14-3-3
family members have been linked to a variety of cancer processes.
While 14-3-3s has been proposed as a tumor suppressor gene
that is silenced or inactivated during progression of melanoma
and breast, gastric, hepatocellular, ovarian and squamous cell
carcinomas [33,36–40]; it has been found overexpressed in
pancreatic cancer [41]. In addition, a proteomic analysis showed
that 14-3-3s expression is downregulated in invasive transitional
cell carcinomas of the urinary bladder undergoing EMT [19].
This is in agreement with our data from human colon cancer
biopsies that show an opposite expression pattern of 14-3-3s and
Snail1. Notably, 14-3-3 e, f and g can form a ternary complex
with Chibby and b-Catenin facilitating nuclear export of b-
Catenin, thereby antagonizing its transcriptional activity that is
an important driver in colon cancer [42]. Contrarily, 14-3-3f
cooperates with ErbB2 to promote EMT and progression of
ductal breast carcinomas to invasive cancer [43], and its
overexpression associates with breast cancer recurrence [44]. In
this study, we have identified 14-3-3 b, e, s, t and f as
downregulated after Snail1 expression in human colon cancer
cells. The action of the 14-3-3 proteins can be modulated by
interaction with different partners in a spatially and temporally
fashion and also is subjected to regulation by phosphorylation.
Therefore, the same 14-3-3 family member can have multiple
and even opposing roles making the analysis of the effect of
individual 14-3-3 proteins very complex and dependent on the
integration of additional signals [45]. Therefore, it is difficult to
predict the role of these proteins in Snail1 action in colon cancer,
which may be related to the mutations typically present in this
neoplasia.
We found that Snail1 represses also PA2G4 expression in
human colon cancer cells. This protein interacts with the
cytoplasmic domain of ErbB3 receptor downregulating ErbB
signal transduction and attenuating heregulin-driven growth of
breast cancer cells [46,47]. PA2G4 is located not only in the
cytosol but also in the nucleus where it behaves as a pleiotropic
protein that interacts with a number of proteins and RNAs
involved in transcriptional regulation and translation control
[48,49]. Thus, PA2G4 inhibits E2F1- and androgen receptor-
mediated transcription through its interaction with retinoblastoma
protein, androgen receptor, several histones deacetylases and
Sin3A [50–53]. The localization of PA2G4 in Cajal bodies that we
have now reported suggests that this multifunctional protein is also
involved in the maturation of snRNA and snoRNA. Moreover,
PA2G4 overexpression induces differentiation of human breast
cancer cells [54], inhibits proliferation of human fibroblasts, and
suppresses growth and metastasis of salivary adenoid cystic
carcinoma cells [55]. From all these studies it is conceivable that
PA2G4 repression may contribute to the tumorigenic action of
Snail1.
Interestingly, Snail1 upregulates the expression of CPSF6 and
SFPQ proteins involved in RNA polyadenylation and splicing,
respectively [56,57]. Both proteins have been recently found to be
present in paraspeckles, a subnuclear compartment proposed to be
Figure 4. Immunofluorescence analysis of 14-3-3 proteins in
Snail1 and Mock cells. Representative confocal microscopy images
showing the expression and localization of 14-3-3 b, e and s (red) in
SW480-ADH Mock and Snail1 cells. GFP expression (green) was
unaltered by Snail1 and was used as a control. Scale bar, 10 mm.
doi:10.1371/journal.pone.0010221.g004
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site for pre-mRNA processing and retention [23]. Of note, both
CPSF6 and SFPQ are fusion partners for tyrosine kinases in
haematological malignancies [58]. Snail1 also alters the splicing
pattern of HNRNPH3, another protein involved in the splicing
process [24]. Intriguingly, the HNRNPH3 isoforms induced by
Snail1 contain two copies of a RNA-binding domain (RNA
recognition motif) commonly found in proteins that bind single-
stranded RNA, while those isoforms repressed by Snail1 contain
only one [24]. However, the functional consequence of this
difference is unknown. Therefore, our study indicates that Snail1
may modulate several steps in RNA maturation, such as
polyadenylation and splicing, and so mRNA stability and
translation. Altogether, these data suggest that in addition to its
recognized transcription repression activity, Snail1 may regulate
gene expression post-transcriptionally by modulating the level of
proteins involved in pre-mRNA processing and location.
In conclusion, our findings implicate Snail1 as a regulator of
previously unpredicted cellular functions in addition to intercel-
lular adhesion and cell morphology. The in-depth study of the
mechanisms of action of the newly identified Snail1 target proteins
will contribute to define the precise complex biological activity of
Snail1 and so the insights of the process of EMT during
embryogenesis and tumorigenesis.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Ethical Committee of the Instituto de Salud Carlos III (Madrid,
Spain) and the Ethical Committee for Clinical Research of the
Institut Municipal d’Assiste`ncia Sanita`ria (Barcelona, Spain). All
patients provided written informed consent for the collection of
samples and subsequent analysis.
Cell culture
SW480-ADH and HT29 human colon cancer cells stably
expressing Snail1 (Snail1 cells) or an empty vector (Mock cells)
were generated by retroviral transduction using pRV-Snail1-
IRES-GFP (Snail1 cells) or pRV-IRES-GFP (Mock cells) vectors
as we have previously reported [10]. Cells were grown in DMEM
supplemented with 10% FCS and 1 mM glutamine (all from
Figure 5. Subcellular distribution of PA2G4. (A) Representative confocal microscopy images showing the expression and localization of PA2G4
(red) in SW480-ADH Mock and Snail1 cells. GFP expression (green) was unaltered by Snail1 and was used as a control. Scale bar, 5 mm. (B)
Representative confocal microscopy images showing double immunolabeling for PA2G4 (red) and for molecular markers (blue) of Cajal bodies
(Coilin), Cajal bodies and nuclear speckles of splicing factors (TMG-cap), nucleolus (Fibrillarin), and PML bodies (PML) in SW480-ADH Mock cells. The
pink colour in the merge images indicates the existence of colocalization. Scale bar, 5 mm.
doi:10.1371/journal.pone.0010221.g005
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Invitrogen, Carlsbad, CA). Phase-contrast images were captured
with a DC300 digital camera (Leica Microsystems, Wetzlar,
Germany) mounted on an inverted Leitz Labovert FS microscope.
Subcellular fractioning
To obtain subcellular fractions, cell monolayers were
washed in PBS and lysed for 15 min in 500 ml hypotonic
buffer (10 mM HEPES pH 7.5, 10 mM KCl, 0.1 mM EDTA,
0.1 mM EGTA) supplemented with 1 mM DDT, 1 mM
ortovanadate, 1 mM PMSF, 10 mg/ml leupeptin and 10 mg/
ml aprotinin. Just before centrifugation (13,000 rpm at 4uC for
10 min), 31.5 ml of 10% NP40 were added to the tubes.
Supernatants containing the cytosolic extracts were main-
tained at 280uC until analysis. Pellets containing nuclei were
lysed by incubation for 30 min in hypertonic buffer (20 mM
HEPES pH 7.5, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA)
supplemented with 1 mM DDT, 1 mM ortovanadate, 1 mM
PMSF, 10 mg/ml leupeptin and 10 mg/ml aprotinin, and then
centrifuged 13,000 rpm at 4uC for 10 min. Supernatants
(nuclear extracts) were conserved at 280uC.
2D-DIGE electrophoresis
Nuclear extracts were precipitated using the 2D Clean-UP kit
(GE Healthcare, Waukesha, WI) and resuspended in the
appropriate 2D-DIGE lysis buffer (7 M urea, 2 M thiourea,
25 mM Tris-HCl pH 8.5, 4% CHAPS) [59]. Fifty mg of each
nuclear protein extract were labeled with 400 pmol CyDyes on ice
for 30 min in the dark as previously described [59,60]. Nuclear
protein extracts from SW480-ADH Mock and Snail1 cells were
labeled with Cy3 and Cy5 fluorochromes, alternating the dyes to
avoid labeling bias. A pool was generated by combining an equal
amount of extract from each cell type. This pool was labeled with
Figure 6. Immunohistochemistry staining of 14-3-3s and Snail1 in human colon tumors. (A) Immunohistochemistry images showing 14-3-
3s expression in representative normal and tumor colon samples of the 46 analyzed in the tissue array. Bars indicate magnification. Sections were
counterstained with haematoxylin. (B) Immunohistochemistry images showing 14-3-3s and Snail1 expression in two consecutive slices of a
representative colon cancer tumor of the five analyzed. Bars indicate magnification. Sections were counterstained with haematoxylin. Right panels
are a 3X-magnification of the region indicated in left panels.
doi:10.1371/journal.pone.0010221.g006
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Cy2 dye and was included in all gel runs. Samples were run using
commercial IPG strips for the IEF (pH 3–10 NL, 24 cm length)
and standard continuous 12% SDS-PAGE for the second
dimension. Finally, a preparative gel containing 500 mg of each
nuclear extract was run and stained with Sypro Ruby (Invitrogen)
for protein visualization and spot picking after matching against
the analytical gels.
Proteins were visualized with the fluorescence scanner Typhoon
9400 (GE Healthcare). The images were processed using DeCyder
software v.6.5. The DeCyder differential in-gel analysis (DIA)
module was used for pair-wise comparisons of SW480-ADH Mock
and Snail1 cells to the mixed standard present in each gel and for
the calculation of normalized spot volumes/protein abundance.
The matching between gels was performed using the internal pool
included in each gel. The 12 spot maps corresponding to four
replica gels were used to calculate average abundance changes and
paired Student’s t-test p-values for each protein across the different
gels. To this end, we used the DeCyder biological variation
analysis (BVA) module and the Cy3:Cy2 and Cy5:Cy2 ratios for
each individual protein. Protein spots that showed a significant
(Student’s t-test, p,0.05) change in abundance between the two
cell types were selected for further characterization by mass
spectrometry.
Identification of proteins by MALDI-TOF-TOF peptide
mass fingerprinting
Spots of interest were excised from the gel automatically using
an Ettan-Picker robot (GE Healthcare) and subjected to tryptic
digestion. Proteins were first reduced (10 mM DTT) and then
alkylated (50 mM iodoacetic acid). Following vacuum-drying, the
gel pieces were incubated with 10 ng/ ml of modified porcine
trypsin (Promega, Madison, WI) in 50 mM ammonium bicarbon-
ate for 16 h at 37uC. Supernatants were collected, vacuum-dried,
re-dissolved in 0.5 ml 0.1% trifluoroacetic acid and added onto a
matrix consisting of 0.5 ml of 5 mg/ml a-ciano-hydroxycynamic in
water:acetonitrile (2:1) with 0.1% trifluoroacetic acid. MALDI-
TOF-TOF analysis of the samples was carried out on a 4800
Instrument (Applied Biosystems, Framingham, MA) in positive ion
reflector mode. Following MS analysis, the instrument was
switched to MS/MS mode, and the five strongest peptides from
the MS scan were isolated and fragmented by collision-induced
dissociation. The ion acceleration voltage was 20 kV. The
obtained MALDI-MS data were further processed using the
GPS Explorer Software (Applied Biosystems) that acts as an
interphase between the Oracle database containing the raw
spectra and a local copy of the MASCOT search engine. The
Homo sapiens subset of the sequences in the SwissProt and Celera
databases were utilized for searches using MASCOT search
engine. Carboxymethylation (Cys) and oxidation (Met) as fixed
and variable modifications, respectively, were taken into account
for database searching. The following search parameters were
used in all MASCOT searches: tolerance of one missed cleavage,
methionine oxidation (+16 Da), and a maximum error tolerance of
100 ppm in the MS data and 0.8 Da in the MS/MS data.
Identification of proteins by peptide sequencing using
ESI-linear ion trap
As MALDI-TOF-TOF analysis failed to identify proteins on
several spots, tryptic peptides were analyzed by nano-HPLC-MS/
MS using an ESI-linear ion trap mass spectrometer (Thermo
Fisher Scientific, Waltham, MA) according to previous protocols
[61]. Peptides were eluted at a 300 nl/min constant flow rate on a
reverse phase PepMap C18 column (75 mm id615 cm) (Dionex,
Sunnyvale, CA) using a 60 min linear gradient from 4 to 60%
solvent B, being solvent A 0.1% formic acid in water and solvent B
0.1% formic acid in acetonitrile. All HPLC runs were performed
using an Ultimate 3000 nano-HPLC system (Dionex) operated at a
300 nl/min constant flow rate. The peptides were scanned and
fragmented with a linear ion trap mass spectrometer (Thermo
Fisher Scientific) equipped with a dynamic nano-ESI source
(Proxeon, Odense, Denmark). An electrospray voltage of 1700 V
and a capillary voltage of 50 V at 190uC were set up.
Fragmentation spectra were searched against SwissProt v.57.4
database using SEQUEST as search engine. The following
parameters were used for searches using SEQUEST v.3.3.1 SP1:
enzyme, trypsin; fixed modifications, carboxymethyl cysteine;
variable modifications, oxidation of methionine; peptide tolerance,
61.50 amu; fragment ion tolerance, 60.5 amu; and number of
missed cleavage sites, 1. All the proteins identified were reanalyzed
using a#1% false positive discovery rate (FDR) cut-off by
searching against a decoy database (a reverse-concatenated
randomized database) using the Proteome Discoverer software
(Thermo Fisher Scientific). Protein location and biological
functions were assigned using the AmiGO software (release date
10/07/09).
Western blotting
To obtain whole-cell extracts, cells were lysed in SDS buffer
(25 mM Tris-HCl pH 7.6, 1 mM EDTA, 1 mM EGTA and 2%
SDS) supplemented with 1 mM ortovanadate, 1 mM PMSF,
10 mg/ml leupeptin and 10 mlg/ml aprotinin. Lysates were
sonicated in a Bioruptor (Diagenode, Lie`ge, Belgium), centrifuged
at 13,000 rpm for 10 min at 4uC and supernatants were conserved
at 280uC. Whole-cell and subcellular extracts were separated by
SDS-PAGE electrophoresis and transferred to Immobilon P
membranes (Millipore, Billerica, MA). The membranes were
incubated with the appropriate primary and secondary horserad-
ish peroxidase-conjugated antibodies, and the antibody binding
was visualized using the ECL detection system (GE Healthcare).
Quantification was done by densitometry using ImageJ software.
The expression of the proteins of interest was then normalized to
that of b-Tubulin (for citosolic extracts) or Lamin B (for nuclear
extracts), and statistical significance was assessed by two-tailed
unpaired Student’s t-test in the indicated cases.
The following primary antibodies were used: 14-3-3b, 14-3-3e,
14-3-3t, 14-3-3f and Lamin B (sc-25276, sc-23957, sc-732, sc-
1019 and sc-6216, Santa Cruz Biotechnology, Santa Cruz, CA);
14-3-3s (012202F, Thermo Fisher Scientific); SFPQ and CPSF6
(H00006421-M02 and H00011052-M10, Abnova Corporation,
Taipei, Taiwan); PA2G4 (07-397, Millipore); HNRNPH3
(ARP40721_T100, Aviva Systems Biology, San Diego, CA); HA
(MMS-101R, Covance, Princeton, NJ); E-cadherin (610181, BD
Biosciences, San Jose, CA); Occludin and Claudin-7 (71-1500 and
34-9100, Invitrogen); Lef-1 (2286, Cell Signaling, Danvers, MA);
and b-Tubulin (T4026, Sigma-Aldrich, St Louis, MO).
Immunofluorescence and confocal microscopy
Cells were rinsed once in PBS, fixed in 3.7% paraformaldehyde
for 15 min at RT and rinsed once in 0.1 M glycine and twice in
PBS. The cells were permeabilized in 0.5% Triton X-100 and
then washed three times in PBS. Nonspecific sites were blocked by
incubation with PBS containing 2% BSA for 30 min at RT before
incubating the cells with the primary antibodies diluted 1/100 in
PBS O/N at 4uC. After four washes in PBS, the cells were
incubated with secondary fluorophore-conjugated antibodies for
45 min at RT, washed and mounted in VectaShield (Vector
Laboratories, Burlingame, CA). For F-actin staining, cells were
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incubated with TRITC-conjugated phalloidin (Sigma-Aldrich) for
15 min at RT and washed in PBS. Confocal microscopy was
performed with a Zeiss LSM510 laser scanning microscope
(Oberkochen, Germany) and using a 63x oil (1.4 NA) objective.
For double labelling experiments, images of the same confocal
plane were sequentially recorded by sequential excitation at 488/
543/633 nm to detect FITC, Cy3 and Cy5, respectively.
We used primary antibodies against: 14-3-3b, 14-3-3s and
PML (sc-25276, sc-100638 and sc-966, Santa Cruz Biotechnolo-
gy); 14-3-3e (610542, BD Biosciences); PA2G4 (07-397, Millipore);
Coilin (ab11822, Abcam, Cambridge, UK); 2,2,7-trimethylgua-
nosine cap (TMG-cap) of spliceosomal small nuclear RNAs
(snRNAs) (NA02, Oncogene Research, San Diego, CA); and
Fibrillarin (72B9) [62].
RNA extraction and quantitative RT-PCR
RNA was extracted from cultured cells using RNeasy Mini Kit
(Qiagen, Hilden, Germany). The level of PA2G4 RNA was
measured by quantitative RT-PCR in relation to that of 18S
rRNA using the comparative CT method and RNA TaqMan
probes (Applied Biosystems). RNA was retrotranscribed using the
High-Capacity cDNA Archive Kit (Applied Biosystems). The
quantitative PCR reaction was performed in an ABI Prism 7900
HT thermal cycler using TaqMan Gene Expression Master Mix
(both from Applied Biosystems). Thermal cycling consisted of a
denaturing step at 95uC for 10 min and 40 cycles of denaturing at
95uC for 15 s and annealing and elongation at 60uC for 60 s.
Statistical significance was assessed by two-tailed unpaired
Student’s t-test, single asterisk indicates p,0.05.
Immunohistochemistry
Tissue arrays containing normal and tumor paired samples
from 46 colorectal cancer patients were prepared as previously
described [63]. These samples were obtained from the Tumor
Bank of Centro Nacional de Investigaciones Oncolo´gicas (Instituto
de Salud Carlos III, Madrid, Spain). The arrays were incubated
with 14-3-3s antibody (diluted 1/50, sc-100638, Santa Cruz
Biotechnology) and visualization of specific interactions was
monitored using the Envision System (Dako, Glostrup, Denmark).
In addition, we studied 14-3-3s and Snail1 expression using
consecutive sections from five human colon tumors obtained from
the Tumor Bank of the Department of Pathology of the Hospital
del Mar (Institut Municipal d’Assiste`ncia Sanita`ria, Barcelona,
Spain). Tissues were sectioned at 4 mm, deparaffined and
rehydrated using xylene and a series of graded ethanol. For
antigen unmasking, sections were immersed in Tris-EDTA pH 8
buffer (10 mM Tris-HCl pH 8, 1 mM EDTA, 10 mM NaCl),
boiled for 5 or 20 min (for 14-3-3s or Snail1, respectively), cooled
at RT for 20 min, and rinsed with PBS. Immunohistochemical
staining was carried out with 14-3-3s antibody (at the same
conditions as above) and with Snail1 antibody (diluted 1/300,
MAb EC) [64] using the PowerVision Poly-HRP Amplification
System (Leica Microsystems) for 14-3-3s and the CSAII
Amplification System (Dako) for Snail1. Sections were counter-
stained with haematoxylin.
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